Recombinant multi-species ABHD5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ABHD5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to a large family of proteins defined by an alpha/beta hydrolase fold, and contains three sequence motifs that correspond to a catalytic triad found in the esterase/lipase/thioesterase subfamily. It differs from other members of this subfamily in that its putative catalytic triad contains an asparagine instead of the serine residue. Mutations in this gene have been associated with Chanarin-Dorfman syndrome, a triglyceride storage disease with impaired long-chain fatty acid oxidation. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1-acylglycerol-3-phosphate O-acyltransferase ABHD5,1300003D03Rik,2010002J10Rik,ABHD5,Abhd5,Abhydrolase domain-containing protein 5,CGI-58,CGI58,IECN2,IECN5,Lipid droplet-binding protein CGI-58,NCIE2
Go
to ABHD5 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP9282-Ag-1/ GM-Tg-hg-IP9282-Ag-2 | Human ABHD5 protein | Human |
| GM-Tg-rg-IP9282-Ag-1/ GM-Tg-rg-IP9282-Ag-2 | Rat ABHD5 protein | Rat |
| GM-Tg-mg-IP9282-Ag-1/ GM-Tg-mg-IP9282-Ag-2 | Mouse ABHD5 protein | Mouse |
| GM-Tg-cynog-IP9282-Ag-1/ GM-Tg-cynog-IP9282-Ag-2 | Cynomolgus/Rhesus macaque ABHD5 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP9282-Ag-1/ GM-Tg-felg-IP9282-Ag-2 | Feline ABHD5 protein | Feline |
| GM-Tg-cang-IP9282-Ag-1/ GM-Tg-cang-IP9282-Ag-2 | Canine ABHD5 protein | Canine |
| GM-Tg-bovg-IP9282-Ag-1/ GM-Tg-bovg-IP9282-Ag-2 | Bovine ABHD5 protein | Bovine |
| GM-Tg-equg-IP9282-Ag-1/ GM-Tg-equg-IP9282-Ag-2 | Equine ABHD5 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP9282-Ag-1/ GM-Tg-hg-IP9282-Ag-2;
GM-Tg-rg-IP9282-Ag-1/ GM-Tg-rg-IP9282-Ag-2;
GM-Tg-mg-IP9282-Ag-1/ GM-Tg-mg-IP9282-Ag-2; GM-Tg-cynog-IP9282-Ag-1/ GM-Tg-cynog-IP9282-Ag-2; GM-Tg-felg-IP9282-Ag-1/ GM-Tg-felg-IP9282-Ag-2; GM-Tg-cang-IP9282-Ag-1/ GM-Tg-cang-IP9282-Ag-2; GM-Tg-bovg-IP9282-Ag-1/ GM-Tg-bovg-IP9282-Ag-2; GM-Tg-equg-IP9282-Ag-1/ GM-Tg-equg-IP9282-Ag-2 |
| Products Name | ABHD5 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ABHD5 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ABHD5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.